Failure of one-day praziquantel treatment in patients with multiple neurocysticercosis lesions

Clinical Neurology and Neurosurgery

Volumn 103, Issue 3, 2001, Pages 175-177

  Pretell, E Javier ^a,b   García, Héctor H ^a,c   Gilman, Robert H ^b,c,d   Saavedra, Herbert ^a   Martinez, Manuel ^a   Rodriguez, S ^a   Padilla, C ^a   Porras, M ^a   Gonzalez, A E ^e   Verastegui, M ^c   Evans, C ^f   Tsang, V C W ^g  

^a INSTITUTO NACIONAL DE CIENCIAS NEUROLÓGICAS   (Peru)

^b ASOCIACIÓN BENÉFICA PRISMA   (Peru)

^c UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e UNIVERSIDAD NACIONAL MAYOR DE SAN MARCOS   (Peru)

^f Science and Technology   (United Kingdom)

^g CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Cysticercosis; Neurocysticercosis; Praziquantel; Taenia solium

Indexed keywords

ANALGESIC AGENT; DEXAMETHASONE; PRAZIQUANTEL;

ADULT; ARTICLE; BRAIN INJURY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HEADACHE; HUMAN; INFLAMMATION; MALE; NAUSEA; NEUROCYSTICERCOSIS; TAENIA SOLIUM; TREATMENT FAILURE; VERTIGO; VOMITING;

ADULT; ANIMALS; ANTHELMINTICS; BRAIN DISEASES; CYSTICERCUS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROCYSTICERCOSIS; PRAZIQUANTEL; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 0034875424     PISSN: 03038467     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-8467(01)00137-8     Document Type: Article

References (21)

1. The Cysticercosis Working Group in Peru (CWG). Cysticercosis as a major cause of epilepsy in Peru
2. Neurocysticercosis as the main cause of late-onset epilepsy in Mexico
3. Immigrants, imaging and immunoblots: the emergence of neurocysticercosis as a significant public health problem
4. Neurocysticercosis
5. T. solium taeniasis/cysticercosis
6. Perilesional gliosis and seizure outcome: a study based on magnetization transfer magnetic resonance imaging in patients with neurocysticercosis
7. Neurocysticercosis: updates on epidemiology, pathogenesis, diagnosis, and management
8. Tratamiento médico de la cisticercosis cerebral
9. Albendazole therapy for cysticercosis
10. Albendazole versus praziquantel for therapy for neurocysticercosis. A controlled trial
11. Short course of albendazole therapy for neurocysticercosis
12. Albendazole therapy for neurocysticercosis: a prospective double blind trial comparing 7 vs. 14 days of treatment
13. Single-day praziquantel therapy for neurocysticercosis
14. An enzyme-linked immunoelectrotransfer blot assay and glycoprotein antigens for diagnosing human cysticercosis (Taenia solium)
15. A short praziquantel regimen for the treatment of parenchymatous neurocysticercosis
16. Porcine cysticercosis: epidemiology, diagnosis and treatment
17. Treatment of swine cysticercosis with oxfendazole: a dose-response trial
18. Effective, single dose treatment of porcine cysticercosis with oxfendazole
19. Treatment of porcine cysticercosis with albendazole
20. Therapy for neurocysticercosis. Comparison between albendazole and praziquantel
21. Single-day praziquantel versus 1-week albendazole for neurocysticercosis